Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -10.04 | -23.41 |
PEG Ratio (TTM) | -0.10 | 15.22 |
P/S Ratio (TTM) | 20.32 | 50.19 |
P/B Ratio (TTM) | 20.68 | 18.75 |
P/FCF Ratio (TTM) | -0.19 | -3.82 |
Price to 5YR AVG Earnings Ratio | -0.11 | -3.63 |
Price to 5YR AVG FCF Ratio | -0.32 | -9.39 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -130.32% | -5.51% |
ROE (TTM) | -184.73% | 15.68% |
Net Profit Margin (TTM) | -21,758.85% | -2,035.83% |
ROIC 5YR AVG | -5,984.76% | 14.56% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -3,467.55% | -21.34% | -2,435.43% |
Revenue | -18.60% | -64.10% | 354.20% |
Net Income | -6.88% | -72.89% | -14,624.38% |
Cash Flow | 7.29% | -66.73% | -39.62% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.45 | 6.23 |
Quick Ratio (TTM) | 3.45 | 5.95 |
D/E Ratio (TTM) | 0.01 | -15.66 |
Interest Coverage (TTM) | -1,849.80 | -1.78 |
Piotroski F-Score | 1 | 5 |
Altman Z-Score | N/A | 14.20 |
LTL to 5YR AVG FCF | -11.25 | 0.17 |
Shares Outstanding Growth 5YR AVG | 4,391.24% | 125.48% |